Seoul National University Bundang Hospital (SNUBH)
Glioblastoma treatment cost in the Republic of Korea is primarily determined by the tumor stage and chosen surgical approach. A brain MRI with contrast typically costs $700 to $1,200, while specialized treatment like Gamma Knife runs from $13,500 to $19,200. Patients often save between 30-50% compared to the United States. High-end neurosurgical care is concentrated in Seoul.
Typical Glioblastoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: For complex glioblastoma cases, multidisciplinary care at JCI-accredited centers in Seoul offers the best value. Severance Hospital provides integrated care with 2,000 doctors at a JCI-certified facility. Patients seeking advanced digital safety should consider Seoul National University Bundang Hospital (SNUBH). It utilizes the BESTcare system for medical safety. Korea University Anam Hospital is ideal for those requiring specialized robotic oncology surgery.
| Republic of Korea | Turkey | Austria | |
| Gamma Knife | from $13,500 | from $6,300 | from $32,000 |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Resection of glioblastoma | - | from $14,400 | - |
| Halcyon | - | from $5,400 | - |
| Actinium-225 Therapy | - | from $22,955 | from $55,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Glioblastoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Glioblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Glioblastoma treatment journey.
Dr. Do Hyun Nam is renowned for endoscopic brain surgeries and tumor removal at Samsung Medical Center – one of South Korea's top hospitals.
The doctor is a leading neurologist in South Korea, specializing in epilepsy treatment. Currently, the doctor serves as the Head of the Neurology Department at Yonsei Severance Hospital.
The doctor graduated from Yonsei University College of Medicine and is an active member of several professional organizations, including The Korean Epilepsy Society, The Korean Neurological Association, and The Korea Medical Association.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
The doctor is a prominent figure in the field of surgery, holding leadership roles such as Director of the Training and Education Committee at the Korean Surgical Society and Director of the Information Technology Committee at the Korean Society of Coloproctology. The doctor also serves as Director of the Surgical Affairs Board at the Korean Society of Gastroenterology and Vice President of the Korean Association of Robotic Surgeons.
With a robust educational background from Korea University, the doctor has demonstrated surgical expertise internationally, including at the Faculty of Medicine, Chinese University of Hong Kong, and Tan Tock Seng Hospital in Singapore.
Glioblastoma surgery in Korea is exceptionally safe for international patients. Facilities maintain a 95% efficacy rate for brain tumor removal procedures. Most top-tier centers hold JCI or KOIHA accreditation. These hospitals utilize fluorescence-guided resection to maximize tumor removal while protecting healthy tissue.
Bookimed Expert Insight: Korea offers a unique safety advantage through its massive patient volumes. Asan Medical Center serves over 11,000 outpatients daily. This high frequency allows surgeons to refine techniques far faster than in lower-volume European centers. When choosing a clinic, prioritize those using 100% digital data systems like SNUH. Electronic health records significantly reduce medication errors for international patients whose records may be complex.
Patient Consensus: Patients emphasize that while Korean technology and surgical equipment are world-class, arranging video consultations before traveling is vital. They also suggest budgeting extra for translation support to ensure clear communication during recovery.
You may receive both awake mapping and fluorescence-guided resection during glioblastoma surgery in South Korea. Glioblastoma is a high-grade tumor often requiring aggressive removal. Surgeons use fluorescence for visualization and mapping to protect functions like speech. These techniques are standard at JCI-accredited centers in Seoul.
Bookimed Expert Insight: Seoul National University Hospital handles over 10,000 patients daily and is a leading choice for glioblastoma. High patient volumes indicate deep expertise in complex neurosurgery. Clinics like Asan Medical Center also maintain Joint Commission International (JCI) accreditation. This ensures they follow the strictest global safety protocols for brain mapping procedures.
Patient Consensus: Patients note that awake surgery sounds scary but feels worth it for a higher resection rate. They recommend asking for functional magnetic resonance imaging (fMRI) beforehand to see if mapping is truly necessary.
Residual tumor cells after glioblastoma surgery in South Korea are managed through aggressive adjuvant therapies. Surgeons often leave microscopic cells to protect healthy brain tissue. Standard protocols include specialized MRI scans within 48 hours. These scans quantify remaining tumor volume to guide immediate chemotherapy or radiation.
Bookimed Expert Insight: Patient data shows Korean hospitals like Seoul National University Hospital achieve high cancer treatment statistics by digitizing surgical workflows. Tracking residual volume within 48 hours is vital. This precision allows doctors to adjust doses for patients with methylated tumors. Such detail often extends survival beyond the typical 15-month mark.
Patient Consensus: Patients emphasize asking for MGMT testing immediately. They note that even with 10% residual tumor, combined therapies and proton centers help maintain a good quality of life.
Glioblastoma treatment in South Korea typically requires an inpatient hospital stay of 7 to 14 days following surgical resection. Initial recovery takes 2 to 4 weeks before starting adjuvant radiation or chemotherapy. Specialized centers manage complex cases with intensive monitoring to ensure neurological stability.
Bookimed Expert Insight: Clinical data shows Seoul National University Bundang Hospital utilizes the BESTcare digital system to prevent errors. This automation shortens recovery by streamlining medication and scan schedules for oncology patients. Choosing a fully digital hospital reduces the risk of post-surgical delays significantly.
Patient Consensus: Patients note the recovery process feels faster due to the highly efficient coordination of nursing staff. Many emphasize that having clear post-surgical instructions helped them transition to home care with lower stress levels.
Preparation for glioblastoma surgery in South Korea requires high-resolution brain MRI scans with contrast. You must provide original DICOM files from the past 1–3 months. Include full pathology reports with molecular markers like IDH and MGMT. Bring these on two backup USB drives. Hospitals often redo tests older than 14 days.
Bookimed Expert Insight: While major centers like Asan Medical Center and Severance Hospital use advanced digital systems, they strictly prioritize high-resolution DICOM data. Our data shows that top-tier Korean facilities, including Seoul National University Hospital, treat thousands of oncology patients daily. Because of this high volume, surgeons usually reject emailed JPGs or simple summaries. Having your records translated into Korean and stored on two separate USB drives prevents delays in these fast-paced environments.
Patient Consensus: Patients note that bringing digital pathology files is vital because simple paper summaries are often rejected. It is helpful to bring a printed medication list to show how your symptoms have progressed.
You can receive both proton-beam and carbon-ion therapy in South Korea. The Yonsei Heavy Ion Therapy Center at Severance Hospital offers carbon-ion treatment. Samsung Medical Center and the National Cancer Center provide proton-beam therapy using high-precision pencil-beam scanning technology for glioblastoma and other brain tumors.
Bookimed Expert Insight: While proton therapy is established, carbon-ion therapy at Severance Hospital is a rare resource. Our data shows Severance manages 4,000,000 patients annually. This high volume suggests their multidisciplinary teams are exceptionally efficient at screening complex glioblastoma cases for these specialized radiation protocols.
Patient Consensus: Patients value the high-tech digital systems at hospitals like SNUH and Severance. They often mention that having international centers helps manage the complex documentation needed for advanced radiation oncology.
The primary neuro-oncology clusters for international patients are located in the United States, Germany, and the Republic of Korea. These hubs feature JCI-accredited facilities specializing in glioblastoma. They offer integrated care including radiosurgery and endoscopic tumor removal to maximize survival rates.
Bookimed Expert Insight: Seoul has become a top neuro-oncology destination due to its massive patient volumes. Asan Medical Center performs over 65,000 operations annually. Korea University Anam Hospital specializes in bloodless surgery. This high intensity allows doctors to master complex glioblastoma protocols quickly. This expertise levels the field with Western centers.